Can IBS cause high calprotectin?

IBS is a common cause of abdominal pain and altered bowel habits, but it is not typically associated with high fecal calprotectin, a stool marker of intestinal inflammation. In this article, you’ll learn what calprotectin measures, how it is used to distinguish IBS from inflammatory conditions like IBD, when elevated levels matter, and why symptoms alone rarely reveal the full picture. We also explain how the gut microbiome influences both IBS symptoms and gut inflammation, and how stool microbiome testing can provide personalized insights to guide conversations with your clinician. If you’ve wondered whether IBS can cause high calprotectin—or what to do if your value is elevated—this guide is for you.

I. Introduction

Understanding IBS: A Common but Complex Gut Disorder

Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by abdominal pain and changes in stool frequency or form, without visible structural disease on standard tests. It affects quality of life, social functioning, and overall wellbeing. While IBS is common, its drivers are diverse—ranging from diet and stress to gut–brain communication, motility, and the microbiome—making each person’s case unique.

The Importance of Accurate Diagnosis in Gut Health

Many digestive disorders share overlapping symptoms. Accurate diagnosis matters because the best management plan depends on what is actually going on in the gut. In particular, distinguishing IBS from inflammatory bowel disease (IBD)—a group of conditions with chronic immune-driven inflammation—can prevent misdiagnosis, reduce unnecessary procedures, and direct the right type of care at the right time.

Exploring the Question: Can IBS Cause High Calprotectin?

Fecal calprotectin is a protein released by neutrophils (a type of white blood cell) when they enter the intestinal lining. It is a reliable, noninvasive marker of intestinal inflammation. Because IBS is defined as a non-inflammatory, functional disorder, IBS by itself does not cause high fecal calprotectin. When calprotectin is elevated, it signals that there is active inflammation somewhere in the gastrointestinal tract, which is more consistent with IBD, infection, or another inflammatory condition.

Setting the Stage: Why This Topic Matters for Your Gut Wellbeing

Understanding what calprotectin does—and doesn’t—tell you helps cut through uncertainty. It reduces the risk of overlooking a problem that needs medical attention and also helps avoid invasive procedures when they aren’t necessary. It can guide more personalized decisions, including when deeper testing (like stool microbiome analysis) can illuminate hidden imbalances that affect IBS symptoms.

II. Core Explanation of the Topic

What Is Calprotectin and Why Is It Significant?

Calprotectin is a complex of two proteins (S100A8/S100A9) abundant in neutrophils. When the gut lining is inflamed, neutrophils migrate into the intestinal mucosa and release calprotectin, which is then shed in stool. Calprotectin is stable at room temperature for a period, making it a convenient and noninvasive biomarker. It correlates, broadly, with the degree of neutrophil-driven inflammation in the gut.

Distinguishing Between IBS (Irritable Bowel Syndrome) and IBD (Inflammatory Bowel Disease)

IBS is a functional disorder without mucosal damage identified on colonoscopy, bloodwork, or imaging. IBD (including Crohn’s disease and ulcerative colitis) involves immune-mediated inflammation and, often, ulcers or structural lesions detected on endoscopy. While both can produce abdominal pain and altered bowel habits, IBD involves ongoing inflammatory activity; IBS does not. This distinction is central to interpreting calprotectin results.

The Role of Calprotectin as a Marker of Gut Inflammation

Fecal calprotectin is widely used to detect and monitor intestinal inflammation. Typical adult reference ranges vary by laboratory, but many use thresholds like:

• Normal: under ~50 μg/g
• Borderline or indeterminate: ~50–150 μg/g (some labs use 100 μg/g as the cutoff)
• Elevated: above ~150–200 μg/g suggests active inflammation
• High: above ~250–300 μg/g strongly indicates significant inflammation (often seen in IBD flares)

These ranges are general; clinical interpretation must consider age, symptoms, medications, recent infections, and lab-specific cutoffs. Children, especially under age 4, can have higher baseline values.

How Calprotectin Levels Are Typically Used in Digestive Health Diagnosis

Clinicians often use fecal calprotectin to help decide whether invasive testing is necessary. When calprotectin is normal and symptoms suggest IBS, invasive procedures may be avoided. When calprotectin is elevated, further evaluation—such as colonoscopy or imaging—may be appropriate to identify inflammation, infection, or other pathology. It also helps monitor known IBD to assess response to therapy and risk of relapse.

Common Assumptions and Misunderstandings About IBS and Inflammation

• Misunderstanding: “IBS is always inflammatory.” Reality: IBS is defined as a non-inflammatory disorder by standard clinical measures; calprotectin is typically normal.
• Misunderstanding: “A normal calprotectin rules out all gut problems.” Reality: You can have troubling IBS symptoms with a normal calprotectin; symptoms can be driven by motility, sensitivity, or microbiome factors without overt inflammation.
• Misunderstanding: “Any elevation must be IBD.” Reality: Elevated calprotectin can reflect multiple causes, including infections, medication effects (e.g., NSAIDs), microscopic colitis, celiac disease, diverticulitis, colorectal neoplasia, and more. Clinical context matters.

III. Why This Topic Matters for Gut Health

The Impact of Misdiagnosis and Symptom Overlap

Abdominal pain, urgency, diarrhea, or constipation occur in many conditions. Without objective markers, people with IBD can be misdiagnosed as having IBS, delaying appropriate care. Conversely, people with IBS may undergo unnecessary investigations. Calprotectin reduces this uncertainty by flagging inflammation that warrants a closer look.

Risks of Overlooking Underlying Inflammation

Missing active inflammation risks progression, complications, and avoidable suffering. Persistent elevations of calprotectin—especially with red flag symptoms like blood in the stool, nocturnal symptoms, weight loss, anemia, or fever—call for prompt medical evaluation.

The Importance of Accurate Differentiation for Effective Treatment

Approaches that help IBS (e.g., dietary adjustments, stress modulation, gut-brain strategies) differ from those needed for IBD (immune-modifying therapies). Differentiating functional symptoms from inflammatory disease enables the right plan. Calprotectin is a practical way to stratify risk and guide next steps.

How Inflammation Guides Management of Gut Disorders

If inflammation is present, addressing it changes the trajectory and goals of care. If inflammation is not present, strategies can prioritize symptom mechanisms such as visceral hypersensitivity, dysregulated motility, food-related triggers, and microbiome imbalances—without unnecessary immunosuppression or invasive procedures.

IV. Related Symptoms, Signals, and Health Implications

Common IBS Symptoms

• Recurrent abdominal pain related to bowel movements
• Changes in stool frequency and/or form (loose, watery, hard, pellet-like)
• Bloating, gas, and a sensation of incomplete evacuation
• Symptoms often fluctuate and may be triggered by eating or stress

Signs That Suggest Possible Inflammation or Other Conditions

• Rectal bleeding or black, tarry stools
• Unintentional weight loss, fever, or night sweats
• Nocturnal diarrhea that wakes you from sleep
• Anemia, persistent fatigue, or elevated inflammatory markers on blood tests
• Family history of IBD or colorectal cancer

These signs do not diagnose a condition, but they raise the likelihood that inflammation or another disease process is present.

Symptoms That Might Signal Elevated Calprotectin Levels

There is no single symptom that definitively predicts a high calprotectin. However, ongoing diarrhea with blood or mucus, urgency with weight loss, and persistent abdominal pain unresponsive to typical IBS strategies are more consistent with inflammatory activity. Many infections also drive temporary calprotectin spikes.

Recognizing When Symptoms Indicate a Need for Further Testing

Consider discussing fecal calprotectin with your clinician if you have:

• New or worsening lower GI symptoms without a clear explanation
• Red flag features (blood in stool, weight loss, nocturnal symptoms)
• Symptoms that do not improve with typical IBS approaches
• A personal or family history raising concern for IBD or other inflammatory conditions

Potential Health Risks of Ignoring Elevated Calprotectin

Ignoring significantly elevated calprotectin can delay diagnosis of IBD, microscopic colitis, chronic infections, diverticulitis, or even neoplasia. While not every elevation is serious, persistent or high values deserve medical follow-up to identify and address the cause appropriately.

V. Individual Variability and Uncertainty in Gastrointestinal Conditions

The Diverse Presentation of IBS Symptoms Across Individuals

IBS is a spectrum. Some people experience diarrhea-predominant symptoms (IBS-D), others constipation-predominant (IBS-C), mixed (IBS-M), or unclassified patterns. Triggers and responses to interventions vary widely. Two people with “IBS” may have very different symptom drivers.

Why Symptom Patterns Alone Do Not Confirm the Underlying Cause

Diarrhea and abdominal pain can occur in both IBS and IBD. Constipation does not exclude inflammation. Infection and bile acid malabsorption can mimic IBS. Relying solely on symptoms risks misclassification. Objective data—like calprotectin, selected blood tests, and, when appropriate, endoscopy—help clarify what’s beneath the surface.

The Challenge of Differentiating IBS from Other Gut Inflammations

Some conditions, such as microscopic colitis or celiac disease, can present much like IBS but involve immune activation. Others, like small intestinal bacterial overgrowth (SIBO), can co-occur with IBS-like symptoms and may or may not affect calprotectin. Differentiation takes careful clinical reasoning supported by targeted testing.

Genetic, Lifestyle, and Microbiome Factors Contributing to Variability

Genes influence immune tone and barrier function. Lifestyle factors—dietary patterns, physical activity, sleep, stress—shape motility and sensitivity. The gut microbiome modulates digestion, metabolite production, and immune signaling. These layers interact, explaining why IBS has many faces and why a personalized approach can be helpful.

VI. Why Symptoms Alone Do Not Reveal the Root Cause

Limitations of Self-Assessment and Symptom-Based Diagnosis

While symptom tracking is valuable, it cannot reveal mucosal inflammation, barrier integrity, or microbial composition. Self-diagnosis based on symptoms may miss red flags or overestimate the significance of transient changes, especially after infections, medication shifts, or dietary changes.

The Overlap Between IBS, Inflammation, and IBD

There is conceptual overlap. Some people with IBS show low-grade immune or mast cell activation on specialized research testing, yet fecal calprotectin remains normal because neutrophilic inflammation is minimal. Conversely, early or mild IBD can present with subtle symptoms. This is why objective measures are crucial.

The Need for Objective Testing to Confirm or Rule Out Inflammation

Fecal calprotectin provides an evidence-based way to assess inflammation noninvasively. Bloodwork (like CRP), celiac screening, and targeted stool pathogen tests may complement calprotectin. These tools prevent guesswork and help ensure that management aligns with biology.

Risks of Relying Solely on Symptoms for Treatment Decisions

Relying only on symptom relief can mask evolving pathology or lead to trial-and-error strategies that miss root contributors. Objective data guide timely escalation or de-escalation of evaluation and support safer, more effective care decisions.

2-minute self-check Is a gut microbiome test useful for you? Answer a few quick questions and find out if a microbiome test is actually useful for you. ✔ Takes 2 minutes ✔ Based on your symptoms & lifestyle ✔ Clear yes/no recommendation Check if a test is right for me →

VII. The Role of the Gut Microbiome in IBS and Inflammation

Introduction to the Gut Microbiome and Its Impact on Digestive Health

The gut microbiome—a vast community of bacteria, archaea, fungi, and viruses—helps digest food, produce vitamins, and generate metabolites like short-chain fatty acids (SCFAs) that nourish colon cells and regulate the immune system. Its composition and function differ between individuals and change with diet, medications, stress, sleep, and illness.

How Microbiome Imbalances (Dysbiosis) May Contribute to IBS Symptoms

Dysbiosis can alter gas production, bile acid metabolism, motility, and visceral sensitivity—all relevant to IBS. For example, reduced SCFA-producing microbes (e.g., Faecalibacterium prausnitzii, Roseburia) may impair barrier support and inflammation control. Overgrowth of certain fermenters can increase bloating. These patterns do not necessarily elevate calprotectin but can drive significant symptoms.

The Connection Between Microbiome Health and Gut Inflammation

Microbial communities influence immune tone through metabolites (SCFAs, tryptophan derivatives), microbial products (lipopolysaccharides), and interactions with the mucosal barrier. When the barrier is compromised (“leaky gut”), luminal antigens can stimulate innate immune responses. In IBD, dysbiosis often includes expansion of potential pathobionts and loss of beneficial SCFA producers; calprotectin rises as neutrophils infiltrate the mucosa.

Can Microbiome Disruptions Drive Elevated Calprotectin Levels?

Yes—when dysbiosis leads to neutrophil-rich mucosal inflammation, calprotectin can rise. This is commonly seen in IBD and acute infections. In IBS, dysbiosis typically affects motility, sensitivity, and fermentation rather than driving marked neutrophilic inflammation; thus calprotectin is usually normal. Post-infectious IBS may show subtle immune changes, but values usually remain below IBD thresholds.

Evidence Supporting the Microbiome-Inflammation Link in IBS

Research shows subsets of IBS have altered microbial profiles, low-grade mucosal immune activation, and increased mast cell activity near enteric nerves. These mechanisms can amplify pain and urgency without producing high stool calprotectin. This nuance explains how someone can feel quite unwell with IBS while standard inflammatory markers remain normal.

VIII. How Microbiome Imbalances May Contribute to Elevated Calprotectin

Types of Microbial Disruptions Associated With Inflammation

• Loss of SCFA-producers (e.g., Faecalibacterium, Roseburia, Eubacterium) that help maintain barrier integrity
• Expansion of Proteobacteria (e.g., certain Escherichia, Klebsiella) associated with pro-inflammatory signals
• Overrepresentation of mucus-degrading species that thin the protective mucous layer
• Fungal overgrowth (e.g., Candida species) potentially interacting with immune pathways

The Role of Specific Bacteria or Fungi in Gut Inflammation

Some strains act as “pathobionts,” behaving harmlessly in balance but promoting inflammation when unchecked. Adherent-invasive E. coli (AIEC) and sulfate-reducing bacteria that generate hydrogen sulfide can impair epithelial function in susceptible hosts. Lower levels of F. prausnitzii are linked with reduced anti-inflammatory signaling in IBD. These patterns are associations; they are not deterministic and must be interpreted individually.

Microbiome-Induced Barrier Dysfunction and Its Effect on Calprotectin

An impaired epithelial barrier allows more microbial and dietary antigens to contact immune cells. This can activate innate responses, recruit neutrophils, and elevate calprotectin in inflammatory conditions. In many IBS cases, barrier disruption may be modest and not sufficient to trigger high neutrophilic influx—hence a normal calprotectin despite significant symptoms.

Understanding the Microbiome’s Influence on Immune Activation in the Gut

Microbes shape immune education via dendritic cells and regulatory T cells. SCFAs like butyrate support regulatory pathways and tight junction integrity. Conversely, microbial products such as LPS engage pattern-recognition receptors and can stimulate pro-inflammatory cascades in susceptible individuals. Whether this translates to elevated calprotectin depends on the intensity and nature of the mucosal response.

IX. How Gut Microbiome Testing Provides Insight

What Is Microbiome Testing and How Is It Conducted?

Stool microbiome testing analyzes the DNA from microbes in a stool sample to characterize community composition and, in some platforms, infer functional potential. Methods include 16S rRNA gene sequencing or shotgun metagenomics. Results provide relative abundances of bacteria (and sometimes fungi and viruses), diversity measures, and functional pathway estimates.

The Benefits of Microbiome Analysis in Context of IBS and Calprotectin Levels

Microbiome testing does not diagnose IBD or IBS, and it does not replace medical evaluation for inflammation. However, it can highlight dysbiosis patterns that help explain symptoms, identify potential triggers, and support personalized strategies. When calprotectin is normal but symptoms persist, microbiome insights can shift the focus toward microbiota-related contributors rather than inflammatory disease.

Key Microbiome Metrics That May Indicate Inflammatory Potential

• Alpha diversity (richness and evenness of species)
• Relative abundance of SCFA-producers
• Relative enrichment of potential pathobionts (e.g., certain Proteobacteria)
• Signatures linked with mucus degradation or oxidative stress
• Functional pathways related to butyrate synthesis, bile acid metabolism, and LPS biosynthesis

Interpreting Microbiome Data: Beyond Standard Gut Tests

Standard clinical tests capture inflammation and structural disease. Microbiome testing offers complementary insights into ecosystem patterns that affect fermentation, gas production, motility, and barrier support. It is best viewed as a decision-support tool that informs diet, lifestyle, and targeted discussions with your clinician.

How Microbiome Testing Can Differentiate Between Functional and Inflammatory Conditions

While not diagnostic, a normal calprotectin alongside microbiome patterns suggestive of dysbiosis supports a functional (non-inflammatory) mechanism. Conversely, dysbiosis with a high calprotectin warrants clinical evaluation for inflammation first; microbiome data may then inform adjunctive strategies. For a practical overview of what stool microbiome analysis entails, see the InnerBuddies microbiome test page.

X. What a Microbiome Test Can Reveal in This Context

Identifying Dysbiosis and Pathogenic Microbes

Testing can identify overrepresentation of organisms associated with gas or bile acid dysregulation, underrepresentation of beneficial fermenters, or the presence of potential pathobionts that may interact with the immune system. It can also flag uncommon signals that merit clinical attention.

Detecting Microbiome Patterns Linked to Inflammation and Symptom Severity

Certain patterns—reduced SCFA producers, expansion of Proteobacteria, and markers of oxidative stress tolerance—are associated with inflammatory states in research. In someone with persistent symptoms, seeing such patterns may guide a discussion about checking calprotectin (if not already done) and, if elevated, pursuing clinical evaluation.

Revealing Microbial Imbalances That May Elevate Calprotectin

When neutrophil-driven mucosal inflammation is present (e.g., IBD flare, infection), microbiome testing often shows reduced diversity and pathobiont expansion. These patterns are supportive but not definitive. Elevated calprotectin should always be evaluated clinically; microbiome results add context, not a diagnosis.

Tailoring Treatment Strategies Based on Microbiome Insights

Findings can inform nutrition choices (e.g., fiber types and fermentability), consideration of low-FODMAP trials, attention to bile acid handling, and targeted adjuncts discussed with a clinician. The aim is to encourage a microbiome milieu that supports barrier integrity and reduces symptom triggers—especially when calprotectin is normal and inflammation is unlikely.

Integrating Microbiome Data With Other Diagnostic Results

Integration is key: combine symptom patterns, calprotectin, selective blood tests, and, when indicated, imaging or endoscopy. Microbiome data can help personalize non-pharmacologic strategies and frame next steps. Learn more about what stool ecosystem data can (and cannot) tell you on our stool microbiome analysis page.

XI. Who Should Consider Microbiome Testing

• People with persistent or recurrent IBS symptoms despite initial strategies
• Individuals with elevated calprotectin who have had evaluation for inflammation but continue to experience symptoms suggestive of dysbiosis
• Those with symptoms suggestive of a functional bowel disorder but unclear dietary or microbial triggers
• Patients who are unresponsive or only partially responsive to standard IBS approaches and want to explore microbiome-related contributors
• Clinicians and patients seeking a fuller picture of microbial balance to inform nutrition and lifestyle discussions

For a clear explanation of what a modern stool ecosystem report includes, review the InnerBuddies microbiome testing overview.

XII. Decision-Support Section: When Does Testing Make Sense?

Key Indicators That Warrant Microbiome and Inflammatory Testing

• New lower-GI symptoms without a clear cause: consider fecal calprotectin to screen for inflammation
• Red flags (blood in stool, nocturnal diarrhea, weight loss, anemia): prioritize medical evaluation and inflammatory testing
• Persistent IBS-like symptoms with normal calprotectin: consider microbiome testing to identify dysbiosis patterns
• Post-infectious symptom onset: calprotectin can transiently rise; recheck after resolution if needed

Differentiating Between IBS Flare-Ups and Potential IBD or Other Conditions

IBS flare-ups often correlate with meals, stress, or hormonal shifts and may respond to dietary adjustments. IBD flares may feature bleeding, urgency, weight loss, and elevated inflammatory markers. Calprotectin helps separate these pathways; sustained elevations suggest looking further for inflammatory causes.

When to Use Calprotectin Levels as a Screening Tool

Calprotectin is helpful for adults with recent-onset lower GI symptoms when serious pathology is not immediately suspected. Borderline results may warrant repeat testing, especially if taken soon after an infection, NSAID use, or intense exercise. High values typically prompt further medical evaluation.

Integrating Testing Results Into Personalized Treatment Plans

Use calprotectin to assess whether inflammation requires attention. If not, focus on functional contributors—motility, sensitivity, food triggers, and dysbiosis. Microbiome testing can guide personalized nutrition and lifestyle strategies while you and your clinician monitor symptoms and, if indicated, repeat objective markers.

The Role of Lifestyle, Diet, and Microbiome Optimization in Managing Symptoms

Regular meals, adequate sleep, physical activity, stress-reduction practices, and an individualized dietary approach can meaningfully impact IBS. Microbiome-informed adjustments—like specific fibers or fermentable foods tailored to your ecosystem—may improve symptoms without targeting inflammation. These strategies are adjuncts to, not replacements for, medical care when inflammation is present.

Key Takeaways

• IBS by itself does not cause high fecal calprotectin; elevated values indicate intestinal inflammation from other causes.
• Fecal calprotectin is a reliable, noninvasive tool to help distinguish IBS from IBD and other inflammatory conditions.
• Borderline or elevated results should be interpreted in context—age, symptoms, medications, and recent infections matter.
• Red flags like bleeding, weight loss, nocturnal diarrhea, or anemia warrant prompt medical evaluation.
• Many IBS symptoms arise from motility, sensitivity, dietary triggers, and microbiome imbalances rather than inflammation.
• Microbiome testing does not diagnose IBD or IBS but offers personalized insight into dysbiosis that may drive symptoms.
• Loss of SCFA-producers and expansion of potential pathobionts are associated with inflammatory states in research.
• Integrating symptoms, calprotectin, labs, and microbiome data supports more informed, individualized care.

Q&A: Can IBS Cause High Calprotectin?

1) Can IBS cause high calprotectin?

No. IBS is a functional bowel disorder and does not typically involve neutrophil-driven mucosal inflammation. Elevated calprotectin suggests another cause, such as IBD, infection, or other inflammatory conditions, and should be evaluated clinically.

2) What calprotectin level is considered high?

Cutoffs vary by lab, but many use under ~50 μg/g as normal, ~50–150 μg/g as borderline, and above ~150–200 μg/g as elevated. Levels above ~250–300 μg/g strongly suggest significant inflammation. Always interpret values with your clinician.

3) Can infections raise calprotectin?

Yes. Gastrointestinal infections commonly elevate calprotectin, sometimes markedly. Levels often normalize after the infection resolves, so timing of testing can influence results.

2-minute self-check Is a gut microbiome test useful for you? Answer a few quick questions and find out if a microbiome test is actually useful for you. ✔ Takes 2 minutes ✔ Based on your symptoms & lifestyle ✔ Clear yes/no recommendation Check if a test is right for me →

4) Do medications affect calprotectin levels?

Nonsteroidal anti-inflammatory drugs (NSAIDs) and, in some cases, other medications may modestly increase calprotectin. Inform your clinician about all medications and supplements when interpreting results.

5) Can stress or diet alone raise calprotectin?

Stress and diet can exacerbate IBS symptoms but generally do not cause high calprotectin because they do not typically induce neutrophil-rich mucosal inflammation. They can, however, influence symptoms through motility and sensitivity pathways.

6) If my calprotectin is normal, can I still have significant symptoms?

Yes. Many IBS symptoms arise from non-inflammatory mechanisms, such as visceral hypersensitivity, altered motility, and dysbiosis. A normal calprotectin helps rule out significant inflammation but does not diminish the real impact of symptoms.

7) What conditions besides IBD can elevate calprotectin?

Infectious colitis, microscopic colitis, celiac disease, diverticulitis, colorectal neoplasia, and acute GI bleeding can raise calprotectin. Age and certain medications can also influence levels. Clinical context guides evaluation.

8) Should I repeat a borderline calprotectin test?

Often, yes. If the value is borderline and you recently had an infection, took NSAIDs, or had intense exercise, repeating after a few weeks can clarify whether the elevation persists. Your clinician can advise on timing.

9) Can microbiome testing replace calprotectin or colonoscopy?

No. Microbiome testing is not a diagnostic test for inflammation or structural disease. It complements, but does not replace, clinical evaluation, calprotectin, bloodwork, imaging, or endoscopy when indicated.

10) How can microbiome testing help if my calprotectin is normal?

It can reveal dysbiosis patterns linked to gas, bloating, motility issues, and barrier support, helping personalize diet and lifestyle strategies. This can be useful when symptoms persist but inflammation is unlikely.

11) If my calprotectin is high, should I still consider microbiome testing?

Address inflammation first with your clinician. Microbiome testing may later inform adjunctive strategies for symptom management and ecosystem support, but it should not delay evaluation of significant inflammation.

12) How often should calprotectin be monitored?

Frequency depends on context. In IBD, it may be tracked to monitor disease activity. In IBS, routine monitoring is usually unnecessary unless symptoms or clinical suspicion change. Decisions should be individualized with your clinician.

XIII. Conclusion: Connecting the Dots Between IBS, Inflammation, and Personal Microbiome

IBS is common and impactful, but it is not typically inflammatory—and it does not cause high fecal calprotectin. When calprotectin is elevated, it signals a need to look for underlying inflammation from IBD or other causes. When calprotectin is normal yet symptoms persist, attention can shift toward functional mechanisms—motility, sensitivity, dietary triggers, and the gut microbiome. Each person’s biology is different; the same symptoms can arise from different roots.

Objective testing reduces guesswork. Calprotectin helps rule in or out significant inflammation, while microbiome testing offers educational insights that may guide personalized, non-pharmacologic strategies. Used together—and interpreted with a clinician—these tools can help you understand your unique gut profile and move toward informed, individualized care.

Keywords

IBS, IBS diagnosis, IBS symptoms, IBS and inflammation, Functional bowel disorder, IBS testing, fecal calprotectin, gut microbiome, dysbiosis, IBD, inflammatory bowel disease, stool testing, SCFA, intestinal permeability, personalized gut health